Dysmenorrhea

Primary Care - Clinics in Office Practice

Volumn 36, Issue 1, 2009, Pages 19-32

  Morrow, Cathleen ^a   Naumburg, Elizabeth H ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cramping; Menstrual flow; Menstrual pain; Pelvic pain; Treatment of dysmenorrhea

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; DANAZOL; DICLOFENAC; DICLOFENAC POTASSIUM; DIFLUNISAL; ETODOLAC; FENAMIC ACID DERIVATIVE; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; KETOROLAC; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; NABUMETONE; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; OXAPROZIN; PIROXICAM; PROSTAGLANDIN E2; PROSTAGLANDIN F2; SULINDAC; TERBUTALINE; UNINDEXED DRUG; VASOPRESSIN; VASOPRESSIN ANTAGONIST;

ACUPUNCTURE; ANXIETY; BODY MASS; CHINESE HERB; CHIROPRACTIC; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DROWSINESS; DRUG COST; DYSMENORRHEA; DYSPEPSIA; EXERCISE; FLUID RETENTION; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTHERMIC THERAPY; HYSTERECTOMY; KIDNEY BLOOD FLOW; KIDNEY FAILURE; LAPAROSCOPIC SURGERY; MENARCHE; MENORRHAGIA; METRORRHAGIA; NAUSEA; NEURECTOMY; NULLIPARA; NUTRITIONAL SUPPORT; OSTEOPATHIC MEDICINE; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PATIENT EDUCATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SIDE EFFECT; SMOKING; SOCIAL NETWORK; STRESS; SYMPTOM; TRANSCUTANEOUS NERVE STIMULATION; UTERUS CONTRACTION;

DYSMENORRHEA; FEMALE; HUMANS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; RISK FACTORS; WOMEN'S HEALTH;

EID: 60649101339     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.10.004     Document Type: Review

References (50)

1. Dawood M.Y. Dysmenorrhea. J Reprod Med 30 3 (1985) 154-167
2. Latthe P., Latthe M., Say L., et al. WHO systematic review of prevalence of chronic pelvic pain: neglected reproductive health morbidity. BMC Public Health 6 (2006) 177
3. Davis A.R., and Westhoff C.L. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 14 (2001) 3-8
4. Banikarim C., Chacko M.R., and Kelder S.H. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med 154 (2000) 1226-1229
5. Sundell G., Milsom I., and Andersch B. Factors influencing the prevalence and severity of dysmenorrhea in young women. Br J Obstet Gynaecol 97 (1990) 588-594
6. Zhang K., Pollack S., Ghoads A., et al. Onset of ovulation after menarche in girls: a longitudinal study. J Clin Endocrinol Metab 93 4 (2008) 1186-1194
7. Juang C.M., Yen M.S., Horng H.C., et al. Natural progression of menstrual pain in nulliparous women at reproductive age: an observational study. J Chin Med Assoc 69 10 (2006) 484-488
8. Dawood M.Y., and Khan-Dawood F.S. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea. Obstet Gynecol 61 3 (1983) 285-291
9. Jabbour H.N., Sales K.J., Smith O.P., et al. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. [Review] [227 refs] Source. Mol Cell Endocrinol 252 1-2 (2006) 191-200
10. Csapo A., and Pinto-Dantas C.R. The cyclic activity of the non-pregnant human uterus. A new method for recording intrauterine pressure. Fertil Steril 17 1 (1966) 34-38
11. Hauksson A., Ekstrom P., Juchnicka E., et al. The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea. Acta Obstet Gynecol Scand 68 1 (1989) 31-34
12. Altunyurt S., Gol M., Altunyurt S., et al. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med 50 (2005) 251-255
13. Liedman R., Skillern L., James I., et al. Validation of a test model of induced dysmenorrhea. Acta Obstet Gynecol Scand 85 4 (2006) 451-457
14. French L. Dysmenorrhea. Am Fam Physician 71 2 (2005) 285-291
15. Andresch B., and Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 144 (1982) 655-660
16. Golding J.M., Wilsnack S.C., and Learman L.A. Prevalence of sexual assault history among women with common gynecologic symptoms. Am J Obstet Gynecol 179 4 (1998) 1013-1019
17. American Society of Health-System Pharmacists. AHFS Drug Information 2008. McEvoy GK, Snow EK, editors. Accessed August 4, 2008. Treatment guidelines from the medical letter: drugs for pain. 2007;5(56):23-5.
18. Treatment guidelines from the medical letter. drugs for pain 5 56 (2007) 23-25
19. Owen P.R. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea: outcome trials reviewed. Am J Obstet Gynecol 148 (1984) 96-103
20. Marjoribanks J., Proctor M.L., and Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhea. Cochrane Database Syst Rev 4 (2003) CD001751
21. Dawood M.Y., and Khan-Dawood F.S. Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea. Am J Obstet Gynecol 196 1 (2007) 35e1-5
22. Chan W.Y., Fuchs F., and Powell A.M. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea. Obstet Gynecol 61 (1983) 285-291
23. Hayes E.C., and Rock J.A. Cox-2 inhibitors and their role in gynecology. Obstet Gynecol Surv 57 (2002) 768-780
24. Smith RP. Dysmenorrhea in gynecology for the primary care physician. In: Stovall TG, Ling FW, Zite NB, et al, editors. 2nd edition. Springer; 2008. p. 335-9.
25. Hendrix S.L., and Alexander N.J. Primary dysmenorrheal treatment with a desogestrel-containing low dose oral contraceptive. Contraception 66 (2002) 393-399
26. Proctor M.L., Roberts H., and Farquhar C.M. Combined oral contraceptives for primary dysmenorrhea. Cochrane Database Syst Rev 4 (2001) CD002120
27. Edelman A.B., Gallo M.F., Jensen J.T., et al. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev (2005) CD004695
28. Baldaszti E., Wimmer-Puchinger B., and Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system: a 3-year follow-up study. Contraception 67 (2003) 87-91
29. Kaunitz A.M. Injectable depot-medroxyprogesterone acetate contraception: an update for US clinicians. Int J Fertil Womens Med 43 (1998) 73-83
30. Nafarelin for endometriosis. The Medical Letter 32 825 (1990) 81-82
31. Andersson D.E., and Ulmsten U. Effect of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhea. Br J Obstet Gynaecol 85 (1978) 142-148
32. Akerlund M., Andersson K.E., and Ingemarsson J. Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhea. Br J Obstet Gynaecol 19 (1976) 303-312
33. Brourd R., Bossmar T., Fournie-Lloret D., et al. Effect of SR49059, an orally active vasopressin receptor antagonist in the prevention of dysmenorrhea. Br J Obstet Gynaecol 107 (2000) 614-619
34. Transdermal Nitroglycerin/Dysmenorrhea Study Group. Transdermal nitroglycerine in the management of pain associated with primary dysmenorrhea: a multinational pilot study. J Int Med Res 25 1 (1997) 41-44
35. Barnard N.D., Scialli A.R., Hurlock D., et al. Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstet Gynecol 95 (2000) 245-250
36. Fjerbaek A., and Knudsen U.B. Endometriosis, dysmenorrhea, and diet - what is the evidence?. Eur J Obstet Gynecol Reprod Biol 132 2 (2007) 140-147
37. Proctor M.L., and Murphy P.A. Herbal and dietary therapies for primary and secondary dysmenorrhea. Cochrane Database Syst Rev 2 (2001) CD002124
38. Zhu X, Proctor M, Bensoussan A, et al. Chinese herbal medicine for primary dysmenorrhea. Cochrane Database Syst Rev 2008;2:CD005288.
39. Proctor M.L., Murphy P.A., Pattison H.M., et al. Behavioral interventions for primary and secondary dysmenorrhea. Cochrane Database Syst Rev 3 (2007) CD002248
40. Proctor M.L., Hing W., Johnson T.C., et al. Spinal manipulation for primary and secondary dysmenorrhea. Cochrane Database Syst Rev 3 (2006) CD002119
41. Proctor M.L., Smith C.A., Farquhar C.M., et al. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhea. Cochrane Database Syst Rev 1 (2002) CD002123
42. Witt C.M., Reinhold T., Brinkhaus B., et al. Acupuncture in patients with dysmenorrhea: a randomized study on clinical effectiveness and cost effectiveness in usual care. Am J Obstet Gynecol 198 2 (2008) 166-168
43. Harlow S.D., and Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 103 11 (1996) 1134-1142
44. Hatcher R.A. Counseling couples about coitus during menstrual flow. Contracept Technol Update 2 12 (1981) 167
45. Akin M.D., Weingand K.W., Hengehold D.A., et al. Use of continuous low level topical heat in the treatment of dysmenorrhea. Obstet Gynecol 97 (2001) 343-349
46. Daley A.J. Exercise and primary dysmenorrhea: a comprehensive and critical review of the literature. Sports Med 38 8 (2008) 859-870
47. Golomb L.M., Solidum A.A., and Warren M.P. Primary dysmenorrhea and physical activity. Med Sci Sports Exerc 30 6 (1998) 906-909
48. 2 laser nerve ablation for treatment of drug resistant primary dysmenorrhea. Fertil Steril 58 (1992) 422-424
49. Chen F.P., Chang S.D., Chu K.K., et al. Comparison of laparoscopic presacral neurectomy and laparoscopic uterine nerve ablation for primary dysmenorrhea. J Reprod Med 41 (1996) 463-466
50. Laththe P.M., Proctor M.L., Farquhar C.M., et al. Surgical interruption of pelvic nerve pathways in dysmenorrhea: a systematic review of effectiveness. Acta Obstet Gynecol Scand 86 1 (2007) 4-15